FindTrial
Sign In

Prospective Safety Study of Danshu capsule in the treatment of chronic cholecystitis with abdominal pain

Prospective Safety Study of Danshu capsule in the treatment of chronic cholecystitis with abdominal pain

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005635
Enrollment
Unknown
Registered
2022-02-10
Start date
2021-11-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cholecystitis

Interventions

Danshu capsule:Do not use similar proprietary Chinese medicine
Danning tablet queue:Do not use similar proprietary Chinese medicine

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with chronic cholecystitis diagnosed by western medicine; 2. Patients with abdominal pain; 3. Patients with stagnation of liver-qi and gallbladder according with syndrome differentiation of traditional Chinese medicine.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Pain VAS score;—

Countries

China

Contacts

Public ContactZhang Shengsheng

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University

zhss2000@163.com13801088329

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026